Related Experiment Video
Updated: Jul 16, 2025

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
Published on: July 25, 2020
Targeting AKT2 in MDA-MB-231 Cells by Pyrazole Hybrids: Structural, Biological and Molecular Docking Studies
Sanjay S Gaikwad1, Snehal K Nimal2, Rushikesh Pol3
1Department of Chemistry, MES, Abasaheb Garware College, Pune, Maharashtra, India-, 411004.
Novel pyrazolic hybrids demonstrate significant cytotoxic effects against triple-negative breast cancer cells and promising antitubercular activity. These compounds show potential as multi-drug candidates due to their ability to inhibit Akt2 and favorable drug absorption properties.
Area of Science:
- Medicinal Chemistry
- Organic Synthesis
- Pharmacology
Background:
- Triple-negative breast cancer (TNBC) remains a challenging malignancy with limited targeted therapies.
- Pyrazolic compounds have shown diverse biological activities, necessitating further exploration for novel therapeutic agents.
- Developing multi-drug candidates with broad-spectrum activity is crucial for combating drug resistance.
Purpose of the Study:
- To synthesize novel pyrazolic hybrids incorporating naphthalene, p-chlorobenzene, o-phenol, and toluene moieties.
- To evaluate the cytotoxic activity of these synthesized compounds against MDA-MB-231 (TNBC) cells.
- To investigate the potential of these compounds as Akt2 inhibitors and assess their drug-likeness and antitubercular activity.
Main Methods:
- Claisen Schmidt condensation reaction was employed for the synthesis of pyrazolic hybrids.
- Spectroscopic techniques (e.g., NMR, Mass Spectrometry) were used for characterization.
- In vitro cytotoxic assays (IC50 determination), in silico molecular docking against Akt2, ADME prediction, and antitubercular activity screening were performed.
Main Results:
- Two compounds, 4b and 5a, exhibited potent cytotoxic activity against MDA-MB-231 cells with IC50 values of 47.72 μM and 24.25 μM, respectively.
- Morphological changes in cancer cells indicated apoptosis induction.
- In silico studies suggested potential inhibition of Akt2 by specific pyrazolic hybrids and favorable pharmacokinetic properties for sub-lingual absorption.
- Promising antitubercular activity was observed for these compounds.
Conclusions:
- The synthesized pyrazolic hybrids demonstrate significant potential as cytotoxic agents against TNBC and as antitubercular agents.
- Compounds with substitutions at less sterically hindered positions showed enhanced activity.
- These pyrazolic hybrids represent promising multi-drug candidates warranting further investigation.
More Related Videos
08:45Assessing Cellular Target Engagement by SHP2 PTPN11 Phosphatase Inhibitors
Published on: July 17, 2020
10:33Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
Published on: October 26, 2015